
17th Annual
T-Cell Lymphoma Forum
January 29-31, 2026

Hyatt Regency La Jolla at Aventine
Conference rate $259
Reservations must be made by December 29, 2025
The 17th Annual T-Cell Lymphoma Forum is the premier global gathering of experts dedicated to advancing the understanding and treatment of T-cell lymphomas. Over two and a half days, the forum will showcase cutting-edge research, emerging therapies, and the latest clinical insights in T-cell lymphoma care.
This year’s agenda features in-depth sessions on molecular pathogenesis, therapeutic innovations, CTCL management, adoptive cellular therapies, and global perspectives on disparities in care. A highlight includes the Fellows Forum, where challenging cases are presented and discussed by leading experts.
Join top scientists, clinicians, and thought leaders in a collaborative environment to tackle pressing challenges and drive progress toward improved patient outcomes.
This activity is not accredited for Continuing Education.
Target audience:
This course has been designed for all clinicians and scientists with an interest in T-cell Lymphoma, including physicians and other healthcare professionals practicing in hematology, oncology, and related fields.
Topics include:
Molecular pathogenesis
Therapeutic innovations
CTCL management
Adoptive cellular therapies
Global perspectives on disparities in care
For more information:
Call for Abstracts
Abstract Submission Opens Soon!

Co-chaired by:
Francine M. Foss, MD
Yale School of Medicine
Won Seog Kim, MD, PhD
Samsung Medical Center
Owen A. O’Connor, MD, PhD
University of Virginia
Joint Accreditation Provider: